Fatty Liver: all 1,462 studies
Page 12 of 15. Open to participants first (289), then studies with results posted, then the rest; newest registration first within each.
- Omega-3 vs Very Low Calorie Diet for Liver Size ReductionStatus unknownNCT03132662Not applicable
- Adding MAraViroc &/or METformin for Hepatic Steatosis in People Living With HIVCompletedNCT03129113Phase 2/3
- Non-invasive Diagnosis of Non-alcoholic Steatohepatitis in Liver Transplant RecipientsStatus unknownNCT03128918
- Vitamin D Replacement in Nonalcoholic Fatty Liver DiseaseCompletedNCT03084328
- Impact of Text Messaging in the Management of Non-alcoholic Fatty Liver DiseaseCompletedNCT03082703Not applicable
- A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 DiabetesCompletedNCT03068078Not applicable
- Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
- Effects of Fructose Restriction on Liver SteatosisCompletedNCT03067428Not applicable
- Screening Diabetes Patients for NAFLD With Controlled Attenuation Parameter and Liver Stiffness MeasurementsCompletedNCT03060694
- A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver DiseaseCompletedNCT03060538Phase 1
- Methods to Detect Liver FibrosisTerminatedNCT03027700Not applicable
- Effects of Combined Dapagliflozin and Exenatide Versus Dapagliflozin and Placebo on Ectopic Lipids in Patients With Uncontrolled Type 2 Diabetes Mellitus.CompletedNCT03007329Phase 4
- Crassostrea Gigas for Liver HealthStatus unknownNCT02992470Not applicable
- The Effects of Zataria Multiflora Boiss (Shirazi's Thyme) on Nonalcoholic Fatty Liver DiseaseCompletedNCT02983669Not applicable
- Single Dose of PF-06835919 Escalation Study in Healthy Adult SubjectsCompletedNCT02974374Phase 1
- Silymarin in NAFLDWithdrawnNCT02973295Phase 4
- Evaluation of the Effects of a L.Reuteri Strain on Markers of Inflammation, Cardiovascular Risk and Fatty Liver DiseaseCompletedNCT02972567Not applicable
- Reversal of Right Ventricular Steatosis in Pulmonary HypertensionWithdrawnNCT02966899Not applicable
- Vitamin E Versus Placebo for the Treatment of Non Diabetic Patients With Nonalcoholic SteatohepatitisCompletedNCT02962297Not applicable
- Metabolic Flexibility, Gut Microbiota, Healthy Diet and Exercise in NAFLD on Genetics BaseCompletedNCT02951546Not applicable
- Breath Analysis Using an Electronic Nose in Non Alcoholic Fatty Liver DiseaseCompletedNCT02950610
- Healthy Eating Through Reduction Of Excess SugarCompletedNCT02948647Not applicable
- Genetical Background of Non-alcoholic Fatty Liver Disease (NAFLD) in Diabetes Mellitus and in Chronic Kidney DiseaseStatus unknownNCT02947568
- Runihol in Nonalcoholic Fatty Liver Disease and Metabolic SyndromeTerminatedNCT02930161Phase 2
- The Effects of Coffee Main Constituents (Caffeine and Chlorogenic Acid) Supplementation on Inflammatory, Metabolic Factors, Hepatic Steatosis and Fibrosis in None- Alcoholic Fatty Liver Patients With Type 2 DiabetesCompletedNCT02929901Phase 2/3
- A Study of the Efficacy and Safety of CF102 in the Treatment of Non-Alcoholic Fatty Liver DiseaseCompletedNCT02927314Phase 2
- Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver DiseaseCompletedNCT02927184Phase 2
- Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD PatientsCompletedNCT02923804Not applicable
- Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH)CompletedNCT02923154Phase 2
- Curcumin Supplement in Nonalcoholic Fatty Liver PatientsCompletedNCT02908152Phase 2/3
- Rifaximin Modify the Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02884037
- Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and PioglitazoneCompletedNCT02875821Phase 4
- Prediction of Donor Liver Adipose Content by Magnetic Resonance ImagingWithdrawnNCT02873507Not applicable
- Diaphragmatic Breathing Exercise Improves Non-alcoholic Fatty Liver DiseaseWithdrawnNCT02863393Not applicable
- Using Infrared Spectroscopy for Diagnosis Severity of Nonalcoholic Fatty Liver DiseaseCompletedNCT02860884
- The Impact of Bariatric Surgery on Non-alcoholic Fatty Liver DiseaseCompletedNCT02828579
- AZD4076 in Type 2 Diabetic Subjects With Non-Alcoholic Fatty Liver Disease.CompletedNCT02826525Phase 1
- Lacto-ovo-vegetarian Diet Riched in Omega-3 Fatty Acids in Menopausal WomenStatus unknownNCT02816814Not applicable
- Hepatic Steatosis and Pituitary Gland Failure, Evaluation by Nuclear Magnetic Resonance (NMR) ImagingCompletedNCT02814240Not applicable
- Pathogenesis of Non-alcoholic Steatohepatitis and Liver Regeneration After Bariatric SurgeryStatus unknownNCT02792634
- A Carbohydrate-restricted Diet to Reverse Fatty Liver in Adolescents With ObesityCompletedNCT02787668Not applicable
- Non-invasive Liver Screening for Risk Assessment for Coronary Heart DiseaseCompletedNCT02779946
- A Study in Adult Patients With Nonalcoholic Steatohepatitis Who Also Have Type 2 DiabetesWithdrawnNCT02769091Phase 2
- Probiotics in the Treatment of NAFLDStatus unknownNCT02764047Not applicable
- Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver DiseaseCompletedNCT02728765Not applicable
- Fecal Microbiota Therapy Versus Standard Therapy in NASH Related Cirrhosis.Status unknownNCT02721264Not applicable
- NASH: Non-invasive Diagnostic Markers and ImagingStatus unknownNCT02717000
- Meta-analyses of the Effect of Important Food Sources of Sugars on Cardiometabolic Risk FactorsStatus unknownNCT02716870
- Meta-analyses of the Effect of Sucrose Versus High Fructose Corn Syrup on Cardiometabolic RiskStatus unknownNCT02702479
- SGLT2 Inhibitors and Metformin on Metabolism and Non-Alcoholic SteatoHepatitisCompletedNCT02696941Phase 1
- Effect of Vitamin E on Non-Alcoholic Fatty Liver DiseaseCompletedNCT02690792Not applicable
- Emricasan, a Caspase Inhibitor, for Evaluation in Subjects With Non-Alcoholic Steatohepatitis (NASH) FibrosisCompletedNCT02686762Phase 2
- Effect of Empagliflozin on Liver Fat Content in Patients With Type 2 DiabetesCompletedNCT02686476Not applicable
- Evaluation of Pancreatic Steatosis in Patients With Cancer of PancreasStatus unknownNCT02682394
- Magnetic Resonance Imaging (MRI) Fat Quantification of the LiverCompletedNCT02682173Not applicable
- The Effects of Type of Exercise in Non-alcoholic Fatty Liver DiseaseCompletedNCT02679417Not applicable
- NAFLD: Independent Effects of Western Dietary Pattern Profile and Sedentary LifeCompletedNCT02670590Not applicable
- Complex Imaging Assessment of SteatosisStatus unknownNCT02669641Phase 4
- Echocardiography, Adherence to Mediterranean Diet (AMDS) and Physical Exercise in Fatty LiverCompletedNCT02669316
- Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients of South Asian DescentCompletedNCT02660047Phase 4
- Impact of Graft Steatosis on Post-operative Complications After Liver TransplantationCompletedNCT02659553
- Cost Effective Non Invasive Diagnostic Modalities and Predictive Model for Development and Progression of Fibrosis Among Patients With Hepatitis B, Hepatitis C Infection or Non Alcoholic Fatty Liver DiseaseWithdrawnNCT02658786
- Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian AdultsStatus unknownNCT02654665Phase 3
- Seum Bile Acid Profile in Type 2 Diabetes and Association Between Bile Cid Profile and Adipokine or Oxidative StressCompletedNCT02650830
- SGLT2 Inhibitor Versus Sulfonylurea on Type 2 Diabetes With NAFLDCompletedNCT02649465Phase 4
- Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)CompletedNCT02649049
- Impact of Ketogenic Diet on Lipoproteins in Refractory EpilepsyStatus unknownNCT02644239Not applicable
- Prebiotics in Patients With Non-alcoholic Liver DiseaseCompletedNCT02642172Not applicable
- Effects of Empagliflozin on Liver Fat Content, Energy Metabolism and Body Composition in Patients With Type 2 DiabetesCompletedNCT02637973Phase 4
- Clinical Validation of a Raman Spectroscope to Determine Hepatic Fat ContentTerminatedNCT02621853Not applicable
- Serine Supplementation for Obese Subjects With Fatty Liver DiseaseCompletedNCT02599038Phase 1/2
- Quantifying Steatosis in Liver Transplant DonorsActive, not recruitingNCT02579408
- Fibroscan® Medical Device, Assessment for Non Invasive Diagnosis of Liver SteatosisCompletedNCT02575625Not applicable
- A Study to Assess ARI-3037MO on Hepatic Fat Metabolism in Patients With Dysglycemia and Evidence of Hepatic SteatosisStatus unknownNCT02574325Phase 2
- A Study to Investigate How the Study Drug SHP626 is Eliminated From the Body After One DoseCompletedNCT02571192Phase 1
- The Effect of an RBAC Supplement (BRM4) on NAFLDCompletedNCT02568787Not applicable
- Prebiotic Fibre Supplementation and Gut Microbiota in Non-alcoholic Fatty Liver DiseaseCompletedNCT02568605Not applicable
- Transforming Non-Invasive Liver Disease Detection by MRE: The HepatogramCompletedNCT02565446Not applicable
- Resolution of Liver Fat in Non-alcoholic Fatty Liver DiseaseCompletedNCT02558530Not applicable
- Clinical Trial to Evaluate the Efficacy of Metadoxine as a Therapy for Patients With Non-alcoholic SteatohepatitisWithdrawnNCT02541045Phase 3
- Effect of Ginger Supplement on Non-alcoholic Fatty LiverCompletedNCT02535195Phase 2/3
- The Effect of Synbiotics Supplement on Lipid Profile, Liver Enzymes, Inflammatory Factors and Hepatic Fibrosis in Lean and Normal Weight Patients With Nonalcoholic Fatty LiverStatus unknownNCT02530138Phase 2/3
- Hepatic Inflammation and Physical Performance in Patients With NASHCompletedNCT02526732Not applicable
- Dynamic Post-Prandial Metabolism in Patients With Non-Alcoholic Fatty Liver DiseaseCompletedNCT02520609
- Safety and Efficacy of Solithromycin in the Treatment of Nonalcoholic Steatohepatitis Without CirrhosisCompletedNCT02510599Phase 2
- Transplantation of Microbes for Treatment of Metabolic Syndrome & NAFLDCompletedNCT02496390Phase 1/2
- Hepatic Steatosis After CholecystectomyStatus unknownNCT02493153
- Safety and Efficacy of HL Tablet in Non-alcoholic Fatty Liver Disease PatientsCompletedNCT02491905Phase 2
- "Hepafast" in Non-alcoholic Fatty Liver Disease (NAFLD)CompletedNCT02491229Not applicable
- Mapping of Metabolic Liver Functions in Patients With Non-alcoholic Fatty Liver DiseaseStatus unknownNCT02488941
- Fecal Microbiota Transplantation (FMT) in Nonalcoholic Steatohepatitis(NASH). A Pilot StudyStatus unknownNCT02469272Phase 1
- Validation of HepaFat-Scan for Noninvasive Measurement of Steatosis in YouthCompletedNCT02461212Not applicable
- Improving Insulin Resistance To Treat Non-Alcoholic Fatty Liver Disease: A Pilot StudyWithdrawnNCT02457286Phase 1
- Comparison of Acoustic Attenuation Parameter Using FibroTouch With Liver Biopsy for Diagnosis of Hepatic SteatosisStatus unknownNCT02456766
- Sedentary Postmenopausal Women With Nonalcoholic Fatty Liver Disease (NAFLD) Submitted to Physical ActivityCompletedNCT02427087Not applicable
- Short Term Intermittent Fasting and Insulin ResistanceStatus unknownNCT02420054Not applicable
- Controlled Trial of WLS vs. CLI for Severely Obese Adolescents With NASHCompletedNCT02412540Not applicable
- Protein-rich Diet and NAFLD in Bariatric SurgeryStatus unknownNCT02400099Not applicable
- The Effects of Flaxseed Supplement on Biochemical Factors and Hepatic Fibrosis in Patients With Nonalcoholic Fatty Liver DiseaseCompletedNCT02395900Phase 2/3
- Impact of Bariatric Surgery on the Evolution of Nonalcoholic Fatty Liver Disease: a Comparative Clinical Trial Between Sleeve Gastrectomy and Gastric BypassCompletedNCT02394353Phase 1